RPG Life Trades at New Lifetime High Today

RPG Life Sciences, a division of the Rs. 20,050 crore RPG Enterprises, is an integrated pharmaceutical company working in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based pharmaceutical company, manufacturing a wide range of quality, affordable medicines. Its brands are greatly trusted by healthcare professionals and patients. Customer satisfaction is essential to the company.

Today, RPG Life share price gained 8.64 per cent and traded at the new lifetime high of Rs. 536.20. The stock’s previous high had been Rs. 534.40 on 21^stSeptember 2016.

RPG Life has been trading almost flat since December 2016. In the September quarter, the company has posted 22 per cent rise in its net sales and 39 per cent increase in its operating profit. RPG Life also posted the highest EPS in past five quarters of Rs.  6.20. The pharma sector company has the market cap of Rs.  816.28 Crore as on 5^th January 2016 and the PE ratio of 30.13.

At 11:35 AM, RPG Life share price was trading at Rs. 526.40, up by 6.66 per cent. So far approximately 4 lakh shares were traded over the NSE trading counter as compared to the twenty day average traded volume of approximately 60 thousand shares. The stock has the Average Daily Movement of 20.73 and has gained approximately 3 per cent in a month. The face value Rs. 8 share has the book value of Rs. 80.77.

RPG Life share price opened at Rs. 496 as compared to its previous close of Rs.  493.55 and went as low as Rs. 493.95. The company’s Dividend yield is seen at 0.32 per cent. For the details on the support and resistance of RPG Life, visit RPG Life share price forecast page f Dynamic Levels website.

RPG Life Share Price Soars After Rise In Q2 Net Sales

RPG Life share price soared over 7 per cent after the company’s net sales for the second quarter ended September 2016 (Q2) stood at Rs 76.38 cr, a growth of 22 per cent, while operating profit at Rs 4.28 cr, demonstrates a growth of 39 per cent on a like-to-like basis i.e., without including the biotech business that was sold to Intas Pharmaceuticals.

A company statement said that the company's net profit for the quarter which stood at Rs 10.25 cr, includes an exceptional profit of Rs 7.38 cr on the back of sale of the biotech business which was concluded at the end of Q1 - first quarter.  

In another deal, the asset purchase agreement for purchase of 7 brands from Sun Pharmaceuticals, was concluded on Friday, and the commercialisation of these brands will start from this quarter.

At 12:02 pm, RPG Life share price was trading 7.02 per cent higher at Rs 502 on the NSE today.

CT Renganathan, Managing Director RPG Life Sciences said that he was glad to report another quarter of above industry performance. He continued that it reflected the many strategic changes that they had undertaken over the last 18 months. The sale of biotech business and the acquisition of 7 brands from Sun Pharmaceutical Industries were steps towards strengthening their business. He added that the consistent strong performance gave them confidence that they were on the right direction. He concluded that they remain focused on growing their domestic and international formulations business. In fact, the international formulations business had grown at 124 per cent in the first half on account of new customers and novel approvals.

According to Dynamic Levels Research Analysts, RPG Life Sciences is a multibagger stock and has the potential to give very good returns. To seek information on the resistance and support levels of the scrip and know more about its fundamentals and financials, please pay a visit to RPG Life share price history.

RPG Life Maintaining the Positive Trend

During the second half of the trading session, RPG Life share price is quoting 11 per cent at Rs. 498.00. The stock opened at Rs. 445 and touched the day’s high and low at Rs. 517.00 and Rs. 441.00.

Drug firm RPG Life Sciences  disclosed a four fold jump in net profit to Rs 10.25 crore for the 2nd quarter ended September 30, on the back of sale of the biotech business. The company had clocked a net profit of Rs 2.56 crore for the same period of the last financial year. Standalone total income from operations also increased to Rs 78.60 crore for the quarter under review as compared to Rs 68.41 crore in the same period a year ago. The profit after tax involves an exceptional profit of Rs 7.38 crore driven by sale of the biotech business which was concluded at the end of the first quarter.

RPG Life share price met its yearly high value at Rs. 534 on 21^st Sep ‘16 whereas the 52 week low value is seen at Rs. 194.70 on 12th Feb ‘16. The company has a market map of Rs. 741.53 (Cr) and has a book value of 80.77. The average daily movement of the stock is 23.85 and the average volume for 20 days is seen at 60141.

RPG Life is a multibagger stock for this quarter as recognized by Dynamic Levels, based on their technical and fundamental research, it is seen to have traded in very high volumes. Multibagger stocks have a great potential to grow in the long run. In order to know about the support and resistance levels of the scrip and also its fundamentals and financials, please a pay a visit to RPG Life  share price history.

RPG Life Races to a New Lifetime High

RPG life share price has traded on a new lifetime high, gaining in the race of top gainers. RPG share price opened at Rs. 439.30 against its previous close of Rs. 436.45. The month of August has been quieter for RPG Life in comparison to June and July. In June, the company tied up with the Italian cosmetic firm Labo Crosprophar and entered into one of India’s fastest growing market- Cosmetology.The company in-licensed two research-based products from the Italian cosmetic firm and launched in the Indian cosmetic market in July. In the month of July, the company bought seven prescription drugs from Sun Pharma for Rs. 41 crores.

Currently, RPG Life share price is trading at Rs. 467.35 with the rise of over 7%.

The company is aiming to quadruple its revenue to Rs. 1,000 crores over next five years. RPG Life is planning to do it through a mix of product in-licensing, product diversification and entry into the US market. RPG Life Sciences is a part of the RPG Group and has an annual turnover of Rs 280 crore as in Financial year 2016, but under C T Renganathan, MD, RPG Life, the company is looking to expand its portfolio, increase exports and enter new markets.

The beginning can be seen in the rise of RPG Life share price that had traded at a new high of Rs. 478.90. The stock has found its cushion on the support level of Rs. 424.25. The company is identified as top 500 performing stock for the quarter by Dynamic Levels. For details on the support and resistance of the stock, visit RPG Life share price forecast page of Dynamic Levels website.